Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Trading Statement

24 Jan 2017 07:00

RNS Number : 8975U
Empresaria Group PLC
24 January 2017
 

24 January 2017

 

Empresaria Group plc

("Empresaria" or the "Group")

Trading Update and Notice of Results

Record profit, ahead of market expectations

 

Empresaria (AIM: EMR), the international specialist staffing group, today announces a trading update for the financial year ended 31 December 2016, ahead of announcing its final results on Wednesday 1 March 2017.

 

The Board is pleased to advise that full year profitability will be slightly ahead of market expectations. Adjusted profit before tax growth is expected to be approximately 23% year on year, representing a record profit level for the Group. Net fee income is approximately 20% ahead of the prior year and diluted adjusted earnings per share is expected to be up 12% on the prior year.

There were strong performances across the Group, with Headway in Germany, Skillhouse in Japan and Monroe in South East Asia all delivering solid growth year on year. In addition, the Group's businesses in Finland, Australia, China, India, Chile and the Technical & Industrial brands in the UK performed well. As announced at the half year, following a short period of uncertainty in the UK prior to the EU referendum, the UK region has seen stable activity levels return. Overall in the UK, this has led to profitability being down year on year, however the Group has reduced costs and is encouraged by the increased business activity as it moves into 2017. In the Middle East, the weak economic conditions persisted in the second half and expected improvements did not materialise. The business has been restructured accordingly and the Group expects an improved result in 2017 from this region.

The Group's USA investment, Pharmaceutical Strategies, is integrating well, having won a number of new clients and improved penetration across key clients. The decision during the year to invest in their management team and their largest client having reduced its overall spend on staffing requirements has resulted in a short-term impact on profitability. Despite this, the business continues to see good growth opportunities going forward.

As part of its 'Invest & Develop' strategy, the Group invested in two international brands in the period, strengthening the Group's presence in key global growth sectors. In July, the Group invested in Rishworth Aviation, the second largest recruitment company in the Aviation sector, operating across the UK, Continental Europe and Asia Pacific regions. The second investment, in October, was ConSol Partners, a specialist IT recruiter with a focus on the niche sectors of communications & mobile, cloud technologies and the digital supply chain, operating across the UK, Continental Europe and USA. Both businesses are performing well and demonstrating positive growth potential for the coming years.

Joost Kreulen, Chief Executive of Empresaria, said:

"Empresaria has demonstrated the benefit of its diversified business model, producing strong results with adjusted profit before tax up 23% on the prior year. We continue to deliver on our strategy: strengthening a multi-branded group, with a focus on developing leading brands that are diversified and balanced by geography and sector.

Alongside the strong growth in a number of regions, we are particularly pleased with the performance of the two international investments made during the year: Rishworth Aviation and ConSol Partners, with both performing well. These, alongside the successful integration of Pharmaceutical Strategies, are all important illustrations of the success of the Group's 'Invest & Develop' strategy and we look forward to the growth opportunity that these businesses have as part of the wider Group.

 

Overall, we are pleased with the record profit the Group has delivered, once again showing the strength of the diversified business model and the strategy the Group is delivering on. As such, we continue to see exciting growth opportunities for the Group in 2017."

 

Enquiries:

 

Empresaria Group plc

Joost Kreulen, Chief Executive Officer

Spencer Wreford, Group Finance Director

 

via Redleaf

Arden Partners (Nominated Adviser and Broker)John Llewellyn-Lloyd / Steve Douglas / Ciaran Walsh

020 7614 5900

Redleaf Communications (Financial PR)Rebecca Sanders Hewett / Sarah Fabietti-Dallison /

Sam Modlin

020 7382 4730

empresaria@redleafpr.com

 

Notes for editors:

 

· Empresaria Group plc is an international specialist staffing group with 21 brands operating in 19 countries across the globe including the UK, Germany, Japan, India, UAE, Indonesia, Chile, Australia, Thailand, Singapore, Finland, USA, New Zealand, China, Malaysia and the Philippines.

· Empresaria offers temporary/contract and permanent staffing solutions as well as Offshore Recruitment Services in seven key sectors: Technical & Industrial, Aviation Services, IT & Design, Professional Services, Healthcare, Executive search and Retail.

· Empresaria applies a multi brand, management equity philosophy and business model, with Empresaria group company management teams holding significant equity in their own business.

· Empresaria is listed on AIM under ticker EMR. For more information: empresaria.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGZMRFDGNZM
Date   Source Headline
25th Jun 20093:20 pmRNSAcquisition of minority stake and issue of equity
24th Jun 20091:50 pmRNSDirector/PDMR Shareholding
18th Jun 20091:26 pmRNSResult of AGM and Annual Report
18th Jun 20097:00 amRNSAGM Statement
22nd May 20097:00 amRNSNotice of AGM
18th May 200911:01 amRNSResult of General Meeting and Issue of Equity)
30th Apr 20097:00 amRNSPlacing and Notice of General Meeting
23rd Apr 20093:36 pmRNSDIRECTOR'S / PDMR DEALINGS AND WINDING UP OF EEPP
9th Apr 20096:00 pmRNSDirector/PDMR Shareholding
31st Mar 20097:00 amRNSFinal Results
30th Jan 20097:00 amRNSTrading Update
29th Jan 20093:31 pmRNSIssue of Equity
26th Jan 200912:00 pmRNSHolding(s) in Company
19th Jan 20091:08 pmRNSDirector dealing
17th Dec 200810:50 amRNSIssue of Equity
15th Dec 20089:35 amRNSJOOST KREULEN HEADS UP EMPRESARIA ASIA OPERATIONS
6th Nov 20085:51 pmRNSHolding(s) in Company
6th Nov 20085:00 pmRNSDirector/PDMR Shareholding
30th Oct 20082:20 pmRNSDirector/PDMR Shareholding
30th Oct 200812:24 pmRNSChange of Adviser Name
14th Oct 200812:48 pmRNSDirector/PDMR Shareholding
16th Sep 200812:40 pmRNSIssue of Equity
9th Sep 20087:00 amRNSInterim Results
4th Aug 20087:09 amRNSEmpresaria Enters Finnish and
15th Jul 20087:00 amRNSEmpresaria Strengthens Asia P
10th Jul 20087:00 amRNSAGM Statement
3rd Jul 20086:22 pmRNSIssue of Equity
18th Jun 20087:00 amRNSNotice of EGM
5th Jun 20084:49 pmRNSDirector/PDMR Shareholding
5th Jun 20087:00 amRNSAnnual Report and AGM
14th May 20088:00 amRNSDirector/PDMR Shareholding
30th Apr 20087:01 amRNSTotal Voting Rights
18th Apr 20087:00 amRNSFinal Results
16th Apr 20087:00 amRNSChange of Adviser
8th Apr 200812:13 pmRNSAcquisition
2nd Apr 20087:01 amRNSDirectorate Change
28th Feb 20084:38 pmRNSHolding(s) in Company
18th Feb 20087:00 amRNSDirector/PDMR Shareholding
15th Feb 20087:00 amRNSDirector/PDMR Shareholding
14th Feb 20087:01 amRNSTrading update
5th Dec 20077:00 amRNSCompletion of Acquisition
7th Nov 200710:18 amRNSAcquisition
6th Nov 200710:39 amRNSHolding(s) in Company
23rd Oct 20074:28 pmRNSHolding(s) in Company
22nd Oct 20073:44 pmRNSHolding(s) in Company
28th Sep 20077:00 amRNSTotal Voting Rights
20th Sep 200711:51 amRNSIssue of Equity
13th Sep 20077:01 amRNSInterim Results
21st Aug 20077:00 amRNSDirector/PDMR Shareholding
20th Aug 200711:36 amRNSAIM Notice (Rule 26)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.